ECG markers of left ventricular hypertrophy indicate response to mavacamten in hypertrophic obstructive cardiomyopathy. [PDF]
Buehning F +9 more
europepmc +1 more source
Surgical Myectomy with Anterior Mitral Leaflet Extension Versus Isolated Myectomy in Patients with Hypertrophic Obstructive Cardiomyopathy. [PDF]
Heeringa TJP +14 more
europepmc +1 more source
Supravalvular aortic stenosis mimicking hypertrophic obstructive cardiomyopathy: a case report. [PDF]
Sharma A, Kaplan E, Betz Y, Ayers M.
europepmc +1 more source
Postoperative Pain After Transapical Beating-Heart Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy: A Retrospective Study. [PDF]
Qiu J +7 more
europepmc +1 more source
Impact of metabolic syndrome on cardiac function and myocardial fibrosis in hypertrophic obstructive cardiomyopathy following septal myectomy assessed by cardiac magnetic resonance. [PDF]
Pan Z +7 more
europepmc +1 more source
Correction: Safety and Effectiveness of Mavacamten Use in Hypertrophic Obstructive Cardiomyopathy: A Systematic Review and Meta-Analysis. [PDF]
Alharbi TY +8 more
europepmc +1 more source
One- and two-year structural changes of mavacamten therapy in hypertrophic obstructive cardiomyopathy: a case report with serial comprehensive CMR demonstrating continuous reverse remodelling. [PDF]
Seuthe K +4 more
europepmc +1 more source
Related searches:
Obstructive Hypertrophic Cardiomyopathy
Progress in Cardiovascular Nursing, 2004Hypertrophic cardiomyopathy (HCM) is a primary disease of cardiac muscle characterized by a thickening of the left ventricular wall and often predominantly affecting the interventricular septum. This paper presents a case study of a 53‐year‐old female with a dynamic and obstructive form of HCM. The study includes a case presentation, clinical findings,
Melissa A, Graham-Cryan +5 more
openaire +2 more sources

